Eliaz Therapeutics, Inc. — Form C (Regulation Crowdfunding)
Eliaz Therapeutics, Inc. of Santa Rosa, CA filed a Form C (Regulation Crowdfunding) with the SEC on 2025-12-08. Target raise $20K, up to $2.5M. Offered through StartEngine Primary, LLC.
Offering
- Filed: 2025-12-08
- Form: C
- Accession: 0002042609-25-000007
- Target amount: $20K
- Maximum amount: $2.5M
- Security type: Other
- Securities offered: 3,597
- Price: $5.5600
- Deadline: 2026-03-09
- Funding portal / intermediary: StartEngine Primary, LLC
- Intermediary file number: 008-70060
Issuer
- CIK: 0002042609
- Website: https://www.eliaztherapeutics.com/
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2015-09-17
- Address: 398 Tesconi Court, Santa Rosa, CA, 95401
- Employees: 5
Financials (as filed)
- Total assets (most recent): $738K
- Cash (most recent): $33K
- Net income (most recent): $-955K
- Net income (prior): $-548K
- Short-term debt: $2.0M
- Long-term debt: $4.2M
People (6)
| Name | Role | Location |
|---|
| Isaac Eliaz | CEO | Santa Rosa, CA |
| Milton Goss | CFO | Santa Rosa, CA |
| Milton Goss | Chief Financial Officer | Santa Rosa, CA |
| Anat Stern | COO and Head of Business Development | Santa Rosa, CA |
| Dr. Isaac Eliaz | CEO, Director, Founder | Santa Rosa, CA |
| Dr. Isaac Eliaz (Md) | CEO | Santa Rosa, CA |
Reg CF filing history (14)
More